GAM Holding’s Heron Therapeutics HRTX Stock Holding History

GAM Holding’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-59,100	Closed	-$2.3M	–	914
2018 Q2	$2.3M	Hold	59,100	–	–	0.08%	262
2018 Q1	$1.63M	Hold	59,100	–	–	0.06%	329
2017 Q4	$1.07M	Hold	59,100	–	–	0.03%	560
2017 Q3	$954K	Hold	59,100	–	–	0.04%	371
2017 Q2	$819K	Hold	59,100	–	–	0.01%	683
2017 Q1	$887K	Hold	59,100	–	–	0.01%	675
2016 Q4	$774K	Hold	59,100	–	–	0.01%	664
2016 Q3	$1.02M	Sell	59,100 -59,100	-50%	-$1.1M	0.02%	610
2016 Q2	$2.13M	Buy	118,200 +59,100	+100%	+$1.15M	0.03%	499
2016 Q1	$1.12M	Buy	59,100 +17,200	+41%	+$339K	0.02%	608
2015 Q4	$1.12M	Buy	41,900 +9,400	+29%	+$251K	0.02%	668
2015 Q3	$793K	Buy	+32,500	New	+$1.08M	0.01%	746

Other funds holding HRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GAM Holding's HRTX Position: Q3 2018 in Review

GAM Holding sold out of Heron Therapeutics (HRTX) in Q3 2018, closing a stake of 59,100 shares — an estimated $2.3M sold.

GAM Holding first reported a position in HRTX in Q3 2015 and held it in 12 quarters. The position peaked at $2.3M in Q2 2018. 194 funds tracked by Wall St. Rank hold HRTX as of Q3 2018.

GAM Holding reported no remaining Heron Therapeutics position as of Q3 2018 after selling out during the quarter.
GAM Holding sold 59,100 Heron Therapeutics shares in Q3 2018, an estimated $2.3M.
GAM Holding first reported a position in Heron Therapeutics in Q3 2015 and held it in 12 quarters.
GAM Holding's Heron Therapeutics position peaked at $2.3M in Q2 2018.
194 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2018.

Based on GAM Holding's 13F filing for Q3 2018, filed 13 Nov 2018.